Phase 1 dose-escalation study of a siRNA targeting the RTP801 gene in age-related macular degeneration patients

for the PF-04523655 Study Group(Johns Hopkins University), Quan Dong Nguyen(Johns Hopkins University), Ronald A. Schachar(Pfizer (United States)), Chudy I. Nduaka(Pfizer (United States)), Marvin Sperling(Pfizer (United States)), Anthony S. Basile(Pfizer (United States)), Karen J. Klamerus(Pfizer (United States)), KS Chi‐Burris(Pfizer (United States)), Elizabeth Yan(Pfizer (United States)), Dario A. Paggiarino(Pfizer (United States)), Irit Rosenblatt(Rabin Medical Center), Anis A. Khan(Quark Pharmaceuticals (United States)), R. Aitchison(Quark Pharmaceuticals (United States)), Shai Erlich(Quark Pharmaceuticals (United States))
Eye
May 25, 2012
10.1038/eye.2012.106
Cited by 70Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis